RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32668216http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32668216http://www.w3.org/2000/01/rdf-schema#comment"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the urgent need for broad-spectrum antiviral countermeasures against SARS-CoV-2 and future emerging CoVs. We report that remdesivir (RDV) potently inhibits SARS-CoV-2 replication in human lung cells and primary human airway epithelial cultures (EC50 = 0.01 μM). Weaker activity is observed in Vero E6 cells (EC50 = 1.65 μM) because of their low capacity to metabolize RDV. To rapidly evaluate in vivo efficacy, we engineered a chimeric SARS-CoV encoding the viral target of RDV, the RNA-dependent RNA polymerase of SARS-CoV-2. In mice infected with the chimeric virus, therapeutic RDV administration diminishes lung viral load and improves pulmonary function compared with vehicle-treated animals. These data demonstrate that RDV is potently active against SARS-CoV-2 in vitro and in vivo, supporting its further clinical testing for treatment of COVID-19."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.org/dc/terms/identifier"doi:10.1016/j.celrep.2020.107940"xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Brown A.J."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Lu X."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Ma B."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Murakami E."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Schafer A."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Gully K."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Chappell J.D."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Baric R.S."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Leist S.R."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Martinez D.R."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Sheahan T.P."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Pruijssers A.J."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Agostini M.L."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Bilello J.P."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Cihlar T."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Denison M.R."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Feng J.Y."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Graham R.L."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Perry J.K."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Stevens L.J."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Pitts J."xsd:string
http://purl.uniprot.org/citations/32668216http://purl.uniprot.org/core/author"Hughes T.M."xsd:string